{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T11:15:53Z","timestamp":1767093353230},"reference-count":40,"publisher":"Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Infect Dis"],"published-print":{"date-parts":[[2017]]},"DOI":"10.7883\/yoken.jjid.2016.234","type":"journal-article","created":{"date-parts":[[2016,12,21]],"date-time":"2016-12-21T22:11:52Z","timestamp":1482358312000},"page":"378-382","source":"Crossref","is-referenced-by-count":8,"title":["Antibiotic Susceptibilities and Genetic Characteristics of Extended-Spectrum Beta-Lactamase-Producing &lt;i&gt;Escherichia coli&lt;\/i&gt; Isolates from Stools of Pediatric Diarrhea Patients in Surabaya, Indonesia"],"prefix":"10.7883","volume":"70","author":[{"given":"Eddy","family":"Bagus Wasito","sequence":"first","affiliation":[{"name":"Department of Microbiology, Faculty of Medicine, Airlangga University\/Dr. Soetomo Hospital"},{"name":"Institute of Tropical Disease, Airlangga University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsumi","family":"Shigemura","sequence":"additional","affiliation":[{"name":"Department of Urology, Kobe University Graduate School of Medicine"},{"name":"Indonesia-Japan Collaborative Research Center for Emerging and Re-emerging Infectious Diseases, Institute of Tropical Disease, Airlangga University"},{"name":"Division of Infectious Diseases, Department of International Health, Kobe University Graduate School of Health Science"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayo","family":"Osawa","sequence":"additional","affiliation":[{"name":"Indonesia-Japan Collaborative Research Center for Emerging and Re-emerging Infectious Diseases, Institute of Tropical Disease, Airlangga University"},{"name":"Division of Infectious Diseases, Department of International Health, Kobe University Graduate School of Health Science"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alpha","family":"Fardah","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine, Airlangga University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiho","family":"Kanaida","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of International Health, Kobe University Graduate School of Health Science"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dadik","family":"Raharjo","sequence":"additional","affiliation":[{"name":"Indonesia-Japan Collaborative Research Center for Emerging and Re-emerging Infectious Diseases, Institute of Tropical Disease, Airlangga University"},{"name":"Institute of Tropical Disease, Airlangga University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Kuntaman","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Faculty of Medicine, Airlangga University\/Dr. Soetomo Hospital"},{"name":"Indonesia-Japan Collaborative Research Center for Emerging and Re-emerging Infectious Diseases, Institute of Tropical Disease, Airlangga University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Usman","family":"Hadi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, Airlangga University\/Dr. Soetomo Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sugeng","family":"Harijono","sequence":"additional","affiliation":[{"name":"Indonesia-Japan Collaborative Research Center for Emerging and Re-emerging Infectious Diseases, Institute of Tropical Disease, Airlangga University"},{"name":"Institute of Tropical Disease, Airlangga University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subijanto","family":"Marto Sudarmo","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine, Airlangga University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Kobe University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keigo","family":"Shibayama","sequence":"additional","affiliation":[{"name":"Department of Bacteriology II, National Institute of Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Fujisawa","sequence":"additional","affiliation":[{"name":"Department of Urology, Kobe University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiro","family":"Shirakawa","sequence":"additional","affiliation":[{"name":"Indonesia-Japan Collaborative Research Center for Emerging and Re-emerging Infectious Diseases, Institute of Tropical Disease, Airlangga University"},{"name":"Center for Infectious Diseases, Kobe University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4631","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Nataro JP, Kaper JB. Diarrheagenic <i>Escherichia coli<\/i>. Clin Micro biol Rev. 1998;11: 142-201.","DOI":"10.1128\/CMR.11.1.142"},{"key":"2","unstructured":"2. Clarke SC. Diarrhoeagenic <i>Escherichia coli<\/i>--an emerging problem? Diagn Microbiol Infect Dis. 2001;41:93-8."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kaper JB, Nataro JP, Mobley HL. Pathogenic <i>Escherichia coli<\/i>. Nat Rev Microbiol. 2004; 2:123-40.","DOI":"10.1038\/nrmicro818"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Hershey CL, Doocy S, Anderson J, et al. Incidence and risk factors for Malaria, pneumonia and diarrhea in children under 5 in UNHCR refugee camps: a retrospective study. Confl Health. 2011;5:24.","DOI":"10.1186\/1752-1505-5-24"},{"key":"5","unstructured":"5. Sadeghabadi AF, Ajami A, Fadaei R, et al. Widespread antibiotic resistance of diarrheagenic <i>Escherichia coli<\/i> and <i>Shigella<\/i> species. J Res Med Sci. 2014;19:S51-5."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Hsueh PR, Hoban DJ, Carmeli Y, et al. Consensus review of the epidemiology and appropriateantimicrobial therapy of complicated urinary tract infections in Asia-Pacific region. J Infect. 2011;63:114-23.","DOI":"10.1016\/j.jinf.2011.05.015"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Coque TM, Baquero F, Canton R. Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveill. 2008;13. pii: 19044.","DOI":"10.2807\/ese.13.47.19044-en"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Hoban DJ, Badal R, Bouchillon S, et al. In vitro susceptibility and distribution of beta-lactamases in Enterobacteriaceae causing intra-abdominal infections in North America 2010\u20132011. Diagn Microbiol Infect Dis. 2014;79:367-72.","DOI":"10.1016\/j.diagmicrobio.2014.03.026"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Bradford PA. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev. 2001;14:933-51.","DOI":"10.1128\/CMR.14.4.933-951.2001"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev. 2005;18:657-86.","DOI":"10.1128\/CMR.18.4.657-686.2005"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Nakamura T, Komatsu M, Yamasaki K, et al. Epidemiology of <i>Escherichia coli, Klebsiella<\/i> species, and <i>Proteus mirabilis<\/i> strains producing extended-spectrum \u03b2-lactamases from clinical samples in the Kinki Region of Japan. Am J Clin Pathol. 2012;137:620-6.","DOI":"10.1309\/AJCP48PDVKWQOXEZ"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Hirakata Y, Matsuda J, Miyazaki Y, et al. Regional variation in the prevalence of extended-spectrum beta-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002). Diagn Microbiol Infect Dis. 2005;52:323-9.","DOI":"10.1016\/j.diagmicrobio.2005.04.004"},{"key":"13","unstructured":"13. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; 22th informational supplement. Document M100-S22. Wayne, PA: CLSI; 2012."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Osawa K, Shigemura K, Shimizu R, et al. Molecular characteristics of extended-spectrum \u03b2-lactamase-producing <i>Escherichia coli<\/i> in a university teaching hospital. Microb Drug Resist. 2015;21:130-9.","DOI":"10.1089\/mdr.2014.0083"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Cao V, Lambert T, Nhu DQ, et al. Distribution of extended-spectrum beta-lactamases in clinical isolates of Enterobacteriaceae in Vietnam. Antimicrob Agents Chemother. 2002;46:3739-43.","DOI":"10.1128\/AAC.46.12.3739-3743.2002"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Osawa K, Raharjo D, Wasito EB, et al. Frequency of diarrheagenic <i>Escherichia coli<\/i> among children in Surabaya, Indonesia. Jpn J Infect Dis. 2013;66:446-8.","DOI":"10.7883\/yoken.66.446"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Jacoby GA, Munoz-Price LS. The new beta-lactamases. N Engl J Med. 2005;352:380-91.","DOI":"10.1056\/NEJMra041359"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Park YS, Bae IK, Kim J, et al. Risk factors and molecular epidemiology of community-onset extended-spectrum \u03b2-lactamase-producing <i>Escherichia coli<\/i> bacteremia. Yonsei Med J. 2014;55:467-75.","DOI":"10.3349\/ymj.2014.55.2.467"},{"key":"19","unstructured":"19. Yagi T, Kurokawa H, Shibata N, et al. A preliminary survey of extended-spectrum beta-lactamases (ESBLs) in clinical isolates of <i>Klebsiella pneumoniae<\/i> and <i>Escherichia coli<\/i> in Japan. FEMS Microbiol Lett. 2000;184:53-6."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Komatsu M, Aihara M, Shimakawa K, et al. Evaluation of Micro Scan ESBL confirmation panel for Enterobacteriaceae-producing, extended-spectrum beta-lactamases isolated in Japan. Diagn Microbiol Infect Dis. 2003;46:125-30.","DOI":"10.1016\/S0732-8893(03)00041-5"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Rodr\u00edguez-Ba\u00f1o J, Navarro MD, Romero L, et al. Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing <i>Escherichia coli<\/i> in nonhospitalized patients. J Clin Microbiol. 2004;42:1089-94.","DOI":"10.1128\/JCM.42.3.1089-1094.2004"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Mugnaioli C, Luzzaro F, De Luca F, et al. CTX-M-type extended-spectrum \u03b2-lactamases in Italy: molecular epidemiology of an emerging countrywide problem. Antimicrob Agents Chemother. 2006;50:2700-6.","DOI":"10.1128\/AAC.00068-06"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Pitout JD, Church DL, Gregson DB, et al. Molecular epidemiology of CTX-M-producing <i>Escherichia coli<\/i> in the Calgary health region: emergence of CTX-M-15-producing isolates. Antimicrob Agents Chemother. 2007;51:1281-6.","DOI":"10.1128\/AAC.01377-06"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Kuenzli E, Jaeger VK, Frei R, et al. High colonization rates of extended-spectrum \u03b2-lactamase (ESBL)-producing <i>Escherichia coli<\/i> in Swiss travellers to South Asia- a prospective observational multicentre cohort study looking at epidemiology, microbiology and risk factors. BMC Infect Dis. 2014;14:528.","DOI":"10.1186\/1471-2334-14-528"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Severin JA, Mertaniasih NM, Kuntaman K, et al. Molecular characterization of extended-spectrum beta-lactamases in clinical <i>Eschbut erichia coli<\/i> and <i>Klebsiella pneumoniae<\/i> isolates from Surabaya, Indonesia. J Antimicrob Chemother. 2010;65:465-9.","DOI":"10.1093\/jac\/dkp471"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Ipekci T, Seyman D, Berk H, et al. Clinical and bacteriological efficacy of amikacin in the treatment of lower urinary tract infection caused by extended-spectrum beta-lactamase-producing <i>Escherichia coli<\/i> or <i>Klebsiella pneumoniae<\/i>. J Infect Chemother. 2014;20:762-7.","DOI":"10.1016\/j.jiac.2014.08.007"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Kang CI, Wi YM, Ko KS, et al. Outcomes and risk factors for mortality in community-onset bacteremia caused by extended-spectrum beta-lactamase-producing <i>Escherichia coli<\/i>, with a special emphasis on antimicrobial therapy. Scand J Infect Dis. 2013;45: 519-25.","DOI":"10.3109\/00365548.2013.775479"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Smet A, Martel A, Persoons D, et al. Characterization of extended-spectrum beta-lactamases produced by <i>Escherichia coli<\/i> isolated from hospitalized and nonhospitalized patients: emergence of CTX-M-15-producing strains causing urinary tract infections. Microb Drug Resist. 2010;16:129-34.","DOI":"10.1089\/mdr.2009.0132"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Brolund A, Edquist PJ, M\u00e4kitalo B, et al. Epidemiology of extended-spectrum \u03b2-lactamase-producing <i>Escherichia coli<\/i> in Sweden 2007\u20132011. Clin Microbiol Infect. 2014;20:344-52.","DOI":"10.1111\/1469-0691.12413"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Alouache S, Estepa V, Messai Y, et al. Characterization of ESBLs and associated quinolone resistance in <i>Escherichia coli<\/i> and <i>Klebsiella pneumoniae<\/i> isolates from an urban wastewater treatment plant in Algeria. Microb Drug Resist. 2014;20:30-8.","DOI":"10.1089\/mdr.2012.0264"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Dahmen S, Haenni M, Ch\u00e2tre P, et al. Characterization of blaCTX-M IncFII plasmids and clones of <i>Escherichia coli<\/i> from pets in France. J Antimicrob Chemother. 2013;68:2797-801.","DOI":"10.1093\/jac\/dkt291"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Naas T, Cuzon G, Bogaerts P, et al. Evaluation of a DNA microarray (Check-MDR CT102) for rapid detection of TEM, SHV, and CTX-M extended-spectrum \u03b2-lactamases and of KPC, OXA-48, VIM, IMP, and NDM-1 carbapenemases. Clin Microbiol. 2011;49:1608-13.","DOI":"10.1128\/JCM.02607-10"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Livermore DM, Canton R, Gniadkowski M, et al. CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother. 2007;59:165-74.","DOI":"10.1093\/jac\/dkl483"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Naas T, Poirel L, Nordmann P. Minor extended-spectrum beta-lactamases. Clin Microbiol Infect. 2008;14:S42-52.","DOI":"10.1111\/j.1469-0691.2007.01861.x"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev. 2005;18:657-86.","DOI":"10.1128\/CMR.18.4.657-686.2005"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Naas T, Oxacelay C, Nordmann P. Identification of CTX-M-type extended-spectrum-beta-lactamase genes using real-time PCR and pyrosequencing. Antimicrob Agents Chemother. 2007;51:223-30.","DOI":"10.1128\/AAC.00611-06"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Bonnet R. Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother. 2004;48:1-14.","DOI":"10.1128\/AAC.48.1.1-14.2004"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Cha MK, Kang CI, Kim SH, et al. Comparison of the microbiological characteristics and virulence factors of ST131 and non-ST131 clones among extended-spectrum \u03b2-lactamase-producing <i>Escherichia coli<\/i> causing bacteremia. Diagn Microbiol Infect Dis. 2016;84:102-4.","DOI":"10.1016\/j.diagmicrobio.2015.10.015"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Aibinu I, Odugbemi T, Koenig W, et al. Sequence type ST131 and ST10 complex (ST617) predominant among CTX-M-15-producing <i>Escherichia coli<\/i> isolates from Nigeria. Clin Microbiol Infect. 2012;18:E49-51.","DOI":"10.1111\/j.1469-0691.2011.03730.x"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Dahmen S, Haenni M, Ch\u00e2tre P, et al. Characterization of blaCTX-M IncFII plasmids and clones of <i>Escherichia coli<\/i> from pets in France. J Antimicrob Chemother. 2013;68:2797-801.","DOI":"10.1093\/jac\/dkt291"}],"container-title":["Japanese Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/70\/4\/70_JJID.2016.234\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T18:48:03Z","timestamp":1658256483000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/70\/4\/70_JJID.2016.234\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.7883\/yoken.jjid.2016.234","relation":{},"ISSN":["1344-6304","1884-2836"],"issn-type":[{"value":"1344-6304","type":"print"},{"value":"1884-2836","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}